Effect of Progesterone on Cerebral Vasospasm and Neurobehavioral Outcomes in a Rodent Model of Subarachnoid Hemorrhage

World Neurosurg. 2018 Feb:110:e150-e159. doi: 10.1016/j.wneu.2017.10.118. Epub 2017 Oct 31.

Abstract

Background: Subarachnoid hemorrhage (SAH) induces widespread inflammation leading to cellular injury, vasospasm, and ischemia. Evidence suggests that progesterone (PROG) can improve functional recovery in acute brain injury owing to its anti-inflammatory and neuroprotective properties, which could also be beneficial in SAH. We hypothesized that PROG treatment attenuates inflammation-mediated cerebral vasospasm and microglial activation, improves synaptic connectivity, and ameliorates functional recovery after SAH.

Methods: We investigated the effect of PROG in a cisternal SAH model in adult male C57BL/6 mice. Neurobehavioral outcomes were evaluated using rotarod latency and grip strength tests. Basilar artery perimeter, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor 1 (GluR1)/synaptophysin colocalization, and Iba-1 immunoreactivity were quantified histologically.

Results: PROG (8 mg/kg) significantly improved rotarod latency at day 6 and grip strength at day 9. PROG-treated mice had significantly reduced basilar artery vasospasm at 24 hours. GluR1/synaptophysin colocalization, indicative of synaptic GluR1, was significantly reduced in the SAH+Vehicle group at 24 hours, and PROG treatment significantly attenuated this reduction. PROG treatment significantly reduced microglial cell activation and proliferation in cerebellum and cortex but not in the brainstem at 10 days.

Conclusions: PROG treatment ameliorated cerebral vasospasm, reduced microglial activation, restored synaptic GluR1 localization, and improved neurobehavioral performance in a murine model of SAH. These results provide a rationale for further translational testing of PROG therapy in SAH.

Keywords: Glutamate receptors; Microglia; Neurobehavioral tests; Progesterone; Subarachnoid hemorrhage; Vasospasm.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Basilar Artery / drug effects
  • Basilar Artery / immunology
  • Basilar Artery / pathology
  • Brain / drug effects
  • Brain / pathology
  • Brain / physiopathology
  • Cell Proliferation / drug effects
  • Cell Proliferation / physiology
  • Disease Models, Animal
  • Male
  • Mice, Inbred C57BL
  • Microglia / drug effects
  • Microglia / pathology
  • Microglia / physiology
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Muscle Strength / drug effects
  • Muscle Strength / physiology
  • Neuroprotective Agents / pharmacology*
  • Progesterone / pharmacology*
  • Random Allocation
  • Receptors, AMPA / metabolism
  • Recovery of Function / drug effects
  • Recovery of Function / physiology
  • Subarachnoid Hemorrhage / drug therapy*
  • Subarachnoid Hemorrhage / pathology
  • Subarachnoid Hemorrhage / physiopathology
  • Synaptophysin / metabolism
  • Vasospasm, Intracranial / drug therapy*
  • Vasospasm, Intracranial / pathology
  • Vasospasm, Intracranial / physiopathology

Substances

  • Anti-Inflammatory Agents
  • Neuroprotective Agents
  • Receptors, AMPA
  • Synaptophysin
  • Progesterone
  • glutamate receptor ionotropic, AMPA 1